anti reverse cap analog (New England Biolabs)
95
Structured Review
New England Biolabs
anti reverse cap analog
Anti Reverse Cap Analog, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+reverse+cap+analog/3OMem7G+(5)ppp+(5)G+RNACapStrucAnalog/pm41997928-225-15-29
Average 95 stars, based on 164 article reviews
Anti Reverse Cap Analog, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+reverse+cap+analog/3OMem7G+(5)ppp+(5)G+RNACapStrucAnalog/pm41997928-225-15-29
Average 95 stars, based on 164 article reviews
anti reverse cap analog - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
other:Article Title: Delivery of a chemically modified noncoding RNA domain improves dystrophic myotube function Article Snippet: In short, Article Title: Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function Article Snippet: In short, Article Title: Translation of HIV-1 unspliced RNA is regulated by 5' untranslated region structure. Article Snippet: HIV-1 must generate infectious virions to spread to new hosts and HIV-1 unspliced RNA (HIV-1 RNA) plays two central roles in this process.. HIV-1 RNA serves as an mRNA that is translated to generate proteins essential for particle production and replication, and it is packaged into particles as the viral genome.. HIV-1 uses several transcription start sites to generate multiple RNAs that differ by a few nucleotides at the 5′ end, including those with one (1G) or three (3G) 5′ guanosines. Article Title: Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function. Article Snippet: In short, Expressing:Article Title: A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection Article Snippet: One experimental HA expression mRNA (also used as an experimental vaccine) was additionally treated with Antarctic Phosphatase (New England Biolabs, Cat. No. M0289S) to dephosphorylate the 5′ end. .. Two mCherry and eGFP expression mRNA vectors (mRNA 1C and 2C in Fig. ) were capped with an Article Title: A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection. Article Snippet: One experimental HA expression mRNA (also used as an experimental vaccine) was additionally treated with Antarctic Phosphatase (New England Biolabs, Cat. No. M0289S) to dephosphorylate the 5′ end. .. Two mCherry and eGFP expression mRNA vectors (mRNA 1C and 2C in Fig. 3) were capped with an Isolation:Article Title: Hijacking innate immunity to enhance mRNA therapeutics by blocking IFN-P-body-XRN1 axis-mediated degradation. Article Snippet: Cap1-GAG (10678ES60) was from Yeasen Biotechnology (Shanghai) Co., Ltd. RQ1 RNase-Free DNase (M6101) was purchased from Promega. .. NEBNext Ultra RNA Library Prep Kit (E7530L), HiScribe T7 High Yield RNA Synthesis Kit (E2040S), Anti-Reverse Cap Analog (ARCA, S1411L), and Synthesized:Article Title: Viral RNA blocks circularization to evade host codon usage control. Article Snippet: Codon usage bias—the preferential use of certain synonymous codons—is a fundamental feature of all genomes.. Codon usage has a key role in determining gene-expression levels in all organisms that have so far been studied.. Nearly all human-infecting viruses show patterns of codon usage that are distinct from those of human genes—yet they express their proteins efficiently in host cells to cause diseases and pandemics. |